Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GPs To Administer Oxford/AstraZeneca Jab As UK Death Toll Grows

Thu, 07th Jan 2021 05:56

(Alliance News) - GP surgeries in England are to begin administering the Oxford/AstraZeneca PLC coronavirus vaccine as the UK faces a race to protect the population after the daily reported death toll topped 1,000.

The drive to mass vaccinate the population will take a considerable step forward as the NHS in England said the jab would be rolled out from GP surgeries from Thursday.

The development comes after the UK reported a further 1,041 people had died within 28 days of testing positive for Covid-19 as of Wednesday – the highest daily reported total since April 21.

Record numbers are also currently in hospital with coronavirus, with a further 3,500 admitted in England on Monday January 4.

Boris Johnson, who was given the overwhelming backing of MPs for the latest lockdown, warned that there was now a race between the spread of the virus and the delivery of vaccines to the most vulnerable.

The House of Commons, recalled from its Christmas break to vote on the lockdown restrictions on Wednesday, voted with a 508 majority for the measures, which could be in place until the end of March.

"After the marathon of last year we are indeed now in a sprint, a race to vaccinate the vulnerable faster than the virus can reach them," the prime minister told MPs.

"Every needle in every arm makes a difference."

It is hoped that more than 700 sites will be delivering vaccines by the end of the week, with the Oxford/AstraZeneca vaccine easier to administer given it can be stored at fridge temperatures, unlike the Pfizer jab which requires storage at minus 70C.

Seven mass vaccination centres will open next week in London, Newcastle, Manchester, Birmingham, Bristol, Surrey and Stevenage.

Vaccines minister Nadhim Zahawi admitted the target of vaccinating around 14 million people in the highest priority groups – including the elderly, those with clinical needs, care home residents and staff as well as frontline NHS workers – by February 15 was "stretching".

Some 1.3 million people have already received either the Pfizer Inc/BioNTech SE or Oxford/AstraZeneca jab.

According to a report in the Daily Mail, the bid to increase the speed of inoculations will see the approval period needed for Covid vaccine batches slashed from 20 days to just four.

The Medicines and Healthcare Regulatory Agency, the body responsible for the checks, is also set to increase staffing in a bid to accelerate the programme, the paper reported.

Ministers have already decided, in a move queried by the World Health Organisation, to administer the first jab to as many priority patients as possible by delaying a second shot.

The second jab will be given 12 weeks later to prevent current supplies from being held back. In the clinical trials, vaccine recipients received a follow-up shot within three weeks.

Johnson was given approval for the latest lockdown in the Commons but faced rebellion within his ranks, with 12 Conservative MPs voting against the stay-at-home rules. They were joined by four DUP MPs opposing the regulations.

In the face of pressure from senior Tories to commit to easing the restrictions – which came into force on Wednesday and were being voted on retrospectively by MPs – as soon as possible, Johnson said there would be "substantial opportunities" for relaxation before March.

Mark Harper, ex-government chief whip and chairman of the lockdown-sceptic Covid Recovery Group, said the restrictions should be reviewed "in the middle of February" once the most vulnerable had been vaccinated, as per the government's aim.

The result came as government data confirmed that the Covid death toll had once again reached levels not seen since the peak of the first wave in 2020.

The figures, however, continue to be affected by a lag in the publication of recent data and contain some deaths that took place over the Christmas and New Year period that have only just been reported.

Of the 1,041 new deaths, around a third took place before January 1, while some 100 took place in the seven days up to Christmas Day.

After the latest mortality figures were released, Labour leader Sir Keir Starmer said ministers had to shoulder some of the blame.

"This is a tragedy. It's not bad luck. It was not inevitable," he tweeted.

"The government has been too slow to react. We now need a national effort to get our country vaccinated."

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.